Moderna exec: Its COVID-19 vaccine likely provides immunity for a yearModerna Inc. expects its COVID-19 vaccine to provide immunity to the virus for at least a year, according to remarks made by a company executive at an investor conference on Monday. Shares of Moderna Inc. were up 0.8% in premarket trading on Tuesday. Moderna developed one of the two authorized COVID-19 vaccines in the U.S. The company is tracking antibodies in participants in its Phase 1, 2, and 3 clinical trials to better understand what level of antibodies are needed to be protected against
Read in MarketWatch: https://apple.news/AOK_n0IDUT2OXDsAq8cozUA
